Table 4.

Most frequent adverse events, incidence (⩾2%) in any treatment group, safety population.

Preferred term	Fluticasone/formoterol	Fluticasone	Fluticasone/salmeterol
	(n = 168)	(n = 172)	(n = 169)
	n (%)	n (%)	n (%)
Patients with at least one AE	38 (22.6)	52 (30.2)	35 (20.7)
Bronchitis	3 (1.8)	2 (1.2)	4 (2.4)
Cough	2 (1.2)	4 (2.3)	2 (1.2)
Nasopharyngitis	4 (2.4)	15 (8.7)	13 (7.7)
Pharyngitis	4 (2.4)	7 (4.1)	4 (2.4)
Rhinitis	8 (4.8)	4 (2.3)	4 (2.4)
Viral rhinitis	1 (0.6)	2 (1.2)	4 (2.4)

AE, adverse event.